Edition:
United States

Aviragen Therapeutics Inc (AVIR.OQ)

AVIR.OQ on NASDAQ Stock Exchange Capital Market

0.59USD
1:41pm EST
Change (% chg)

$0.00 (+0.02%)
Prev Close
$0.59
Open
$0.59
Day's High
$0.59
Day's Low
$0.58
Volume
6,472
Avg. Vol
97,205
52-wk High
$1.48
52-wk Low
$0.44

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Mark Colonnese

61 2015 Chief Financial Officer, Executive Vice President

Russell Plumb

57 2014 Executive Chairman of the Board

Joseph Patti

52 2014 President, Chief Executive Officer, Director

Armando Anido

59 2015 Independent Director

Geoffrey Cox

72 2012 Independent Director